SCHEMBL19000232

SCHEMBL19000232

CC(NC(=O)c1sc2nc3c(cc2c1N)CN(C)CC3)[C@@]12CC=CC3C[C@H](CN31)C2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
KMT2A Q03164 4/20 0.57
MEN1 O00255 3/20 0.57
POLB P06746 2/20 0.57
LMNA P02545 1/20 0.57
HSP90AA1 P07900 1/20 0.57
GAA P10253 1/20 0.57
HPGD P15428 1/20 0.57
PTK2B Q14289 1/20 0.57
MAPT P10636 14/20 0.55
KDM4E B2RXH2 3/20 0.55
CYP1A2 P05177 1/20 0.54
CYP2C19 P33261 1/20 0.54
NPSR1 Q6W5P4 2/20 0.51
ADORA2A P29274 1/20 0.51
USP2 O75604 1/20 0.51
THRB P10828 1/20 0.51
ALOX15 P16050 1/20 0.51
CASP1 P29466 1/20 0.51
BRCA1 P38398 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL431860 0.81 ALDH1A1 (0.73) ALDH1A1KMT2AMEN1POLBLMNA
SCHEMBL18818613 0.81 ALDH1A1 (0.73) ALDH1A1KMT2AMEN1POLBLMNA
SCHEMBL18537661 0.81 ALDH1A1 (0.73) ALDH1A1KMT2AMEN1POLBLMNA
SCHEMBL428803 0.77 ALDH1A1 (0.76) ALDH1A1KMT2AMEN1POLBLMNA
SCHEMBL13186361 0.76 ALDH1A1 (0.64) ALDH1A1KMT2AMEN1POLBLMNA
SCHEMBL15788373 0.74 ALDH1A1 (0.79) ALDH1A1KMT2AMEN1POLBLMNA
SCHEMBL17791874 0.73 MAPT (0.62) ALDH1A1KMT2AMEN1POLBLMNA
SCHEMBL428713 0.72 MAPT (1.00) ALDH1A1KMT2AMEN1POLBLMNA
SCHEMBL13186294 0.71 MAPT (0.77) ALDH1A1KMT2AMEN1POLBLMNA
SCHEMBL429191 0.71 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3181568-A1 THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS Siga Technologies, Inc. (US) 2017-06-21 EP disclosed